Abiopharma

News list

Parker John David 🟢 acquired 20.0K shares (1 derivative) of Marcus & Millichap, Inc. (MMI) Transaction Date: May 04, 2026 | Filing ID: 000006

Full text

News bot May 7, 2026, 1:12 a.m.
🔍 Parker John David (Executive)

Company: Marcus & Millichap, Inc. (MMI)

Report Date: 2026-05-04
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 20,000
Detailed Transactions and Holdings:
- Acquired 20,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-04 | Code: A | equity_swap_involved: false | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F2: The restricted stock units vest in five equal annual installments beginning June 10, 2027